MJ-05

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMJ-05
Drug Alias Namep53 activators (Karolinska Institute)MJ-05
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 stimulants
TargetsTumor protein p53
Therapy Area/IndicationsLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKarolinska Institutet
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKarolinska Institutet
Active IndicationsN/A
Inactive IndicationsLeukemia, Myelogenous, Chronic

Other Information

ATC CodeN/A
Related LinksN/A